Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mara L Becker

Showing results (51-60 of 77) with videos related to

Pageof 8
Sort By:
Arthritis Care & Research|August 29, 2013
Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance RegistryAngela Byun Robinson, Mark F Hoeltzel, Dawn M Wahezi, et al.
Journal of Pediatric Intensive Care|November 17, 2022
Use of Electronic Health Records to Identify Exposure-Response Relationships in Critically Ill Children: An Example of Midazolam and DeliriumKanecia O Zimmerman, Tracy G Spears, Marjan Cobbaert, et al.
Journal of Neurodevelopmental Disorders|March 24, 2022
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working groupNicole T Baumer, Mara L Becker, George T Capone, et al.
Arthritis Care & Research|April 24, 2014
Choosing Wisely: the American College of Rheumatology's Top 5 for pediatric rheumatologyKelly A Rouster-Stevens, Stacy P Ardoin, Ashley M Cooper, et al.
The Journal of Rheumatology|October 17, 2019
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized SclerodermaSuzanne C Li, Kathryn S Torok, C Egla Rabinovich, et al.
Arthritis Care & Research|December 27, 2023
Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity ScaleSuzanne C Li, C Egla Rabinovich, Mara L Becker, et al.
Pediatric Rheumatology Online Journal|July 17, 2019
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot studySuzanne C Li, Robert C Fuhlbrigge, Ronald M Laxer, et al.
Rheumatology (Oxford, England)|June 6, 2017
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexateHalima Moncrieffe, Mark F Bennett, Monica Tsoras, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Inosine triphosphate pyrophosphatase activity as a potential predictor of methotrexate remission in juvenile idiopathic arthritisSofia Sindici Forgiarini, Marianna Lucafò, Debora Curci, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Pageof 8

Showing results (51-60 of 77) with videos related to

Sort By:
Pageof 8
Arthritis Care & Research|August 29, 2013
Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance RegistryAngela Byun Robinson, Mark F Hoeltzel, Dawn M Wahezi, et al.
Journal of Pediatric Intensive Care|November 17, 2022
Use of Electronic Health Records to Identify Exposure-Response Relationships in Critically Ill Children: An Example of Midazolam and DeliriumKanecia O Zimmerman, Tracy G Spears, Marjan Cobbaert, et al.
Journal of Neurodevelopmental Disorders|March 24, 2022
Conducting clinical trials in persons with Down syndrome: summary from the NIH INCLUDE Down syndrome clinical trials readiness working groupNicole T Baumer, Mara L Becker, George T Capone, et al.
Arthritis Care & Research|April 24, 2014
Choosing Wisely: the American College of Rheumatology's Top 5 for pediatric rheumatologyKelly A Rouster-Stevens, Stacy P Ardoin, Ashley M Cooper, et al.
The Journal of Rheumatology|October 17, 2019
Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized SclerodermaSuzanne C Li, Kathryn S Torok, C Egla Rabinovich, et al.
Arthritis Care & Research|December 27, 2023
Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity ScaleSuzanne C Li, C Egla Rabinovich, Mara L Becker, et al.
Pediatric Rheumatology Online Journal|July 17, 2019
Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot studySuzanne C Li, Robert C Fuhlbrigge, Ronald M Laxer, et al.
Rheumatology (Oxford, England)|June 6, 2017
Transcriptional profiles of JIA patient blood with subsequent poor response to methotrexateHalima Moncrieffe, Mark F Bennett, Monica Tsoras, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 24, 2026
Inosine triphosphate pyrophosphatase activity as a potential predictor of methotrexate remission in juvenile idiopathic arthritisSofia Sindici Forgiarini, Marianna Lucafò, Debora Curci, et al.
Arthritis Care & Research|January 29, 2023
Patient-Reported Outcomes Among Patients Ages Two to Seventeen Years With Polyarticular-Course Juvenile Idiopathic Arthritis Treated With Subcutaneous Abatacept: Two-Year Results From an International Phase III StudyNicolino Ruperto, Daniel J Lovell, Alberto Berman, et al.
Pageof 8